Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20080078411 A1
Publication typeApplication
Application numberUS 11/542,455
Publication dateApr 3, 2008
Filing dateOct 3, 2006
Priority dateOct 3, 2006
Also published asUS7845357, US20100059065
Publication number11542455, 542455, US 2008/0078411 A1, US 2008/078411 A1, US 20080078411 A1, US 20080078411A1, US 2008078411 A1, US 2008078411A1, US-A1-20080078411, US-A1-2008078411, US2008/0078411A1, US2008/078411A1, US20080078411 A1, US20080078411A1, US2008078411 A1, US2008078411A1
InventorsPaul J. Buscemi, Kurt D. Krueger
Original AssigneeRestore Medical, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Tongue implant for sleep apnea
US 20080078411 A1
Abstract
A patient's obstructive sleep apnea is treated by identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient. The method includes identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue and stiffening a tissue of the tongue throughout the identified region.
Images(8)
Previous page
Next page
Claims(9)
1. A method for treating obstructive sleep apnea comprising:
identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient;
identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue;
stiffening a tissue of the tongue throughout the identified region.
2. A method according to claim 1 wherein the identified region includes an area of the base of the tongue opposing the pharyngeal wall between an epiglottis and a trailing end of a soft palate.
3. A method according to claim 1 wherein the identified region includes an area of the base of the tongue between lateral extremities of the base of the tongue.
4. A method according to claim 1 wherein said stiffening includes placing an implant of fibrosis-inducing material within the tongue with the implant extending throughout said region with the material selected to induce formation of fibrosis along said region.
5. A method according to claim 4 wherein said implant is sized for said region to extend substantially between an epiglottis and a soft palate of the patient at the base of the tongue.
6. A method according to claim 5 wherein said implant is a substantially planar sheet placed in the tongue with a narrow dimension extending transverse to the tongue and having a proximal end within said region at said mandibular-geniohyoid interface and with a distal end within the tongue at the base and extending between the epiglottis and the soft palate.
7. A method according to FIG. 4 wherein said implant is a tubular material selected to induce fibrosis formation and with a proximal end at said mandibular-geniohyoid interface and with a distal end at said base of the tongue.
8. A method according to claim 7 wherein said region includes an area of the base of the tongue between lateral extremities of the base of the tongue and said method includes placing multiples of said implants in a volume of said tongue within said region.
9. A method according to claim 1 according to claim 4 wherein said material is selected for said implant to contract and expand with the tongue as the tongue heals.
Description
    I BACKGROUND OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    This invention pertains to a method for treating a condition of an upper airway of a patient. More particularly, this invention is directed to a method for treating obstructive sleep apnea by stiffening a tongue of a patient.
  • [0003]
    2. Description of the Prior Art
  • [0004]
    Upper airway conditions such as obstructive sleep apnea (“OSA”) and snoring have received a great deal of attention. These conditions have recognized sociological and health implications for both the patient and the patient's bed partner.
  • [0005]
    Numerous attempts have been made towards treating OSA and snoring. These include placing implants in either the tissue of the soft palate or the pharyngeal airway as disclosed in commonly assigned U.S. Pat. No. 6,250,307 to Conrad et al. dated Jun. 26, 2003, U.S. Pat. No. 6,523,542 to Metzger et al. dated Feb. 25, 2003 and U.S. Pat. No. 6,431,174 to Knudson et al. dated Aug. 13, 2002. Further, U.S. Pat. No. 6,601,584 to Knudson et al. dated Aug. 5, 2003 teaches a contracting implant for placement in the soft palate of the patient.
  • [0006]
    Another prior art technique for treating OSA or snoring is disclosed in U.S. Pat. No. 5,988,171 to Sohn et al. dated Nov. 23, 1999. In the '171 patent, a cord (e.g., a suture material) (element 32 in FIG. 6 of the '171 patent) is placed surrounding a base of the tongue and secured to the jaw by reason at an attachment member (element 20 in FIG. 6 of the '171 patent). In the method of the '171 patent, the member 32 can be shortened to draw the base of the tongue toward the jaw and thereby move the tissue of the base of the tongue away from the opposing tissue of the pharyngeal airway. However, this procedure is often uncomfortable. This procedure, referred to as tongue suspension, is also described in Miller et al., “Role of the tongue base suspension suture with The Repose System bone screw in the multilevel surgical management of obstructive sleep apnea”, Otolaryngol. Head Neck Surg., Vol. 126, pp. 392-398 (2002).
  • [0007]
    Another technique includes debulking tissue by applying radio frequency ablation to either the tongue base or of the soft palate to debulk the tissue of the tongue or palate, respectively. This technique is illustrated in U.S. Pat. No. 5,843,021 to Edwards et al. dated Dec. 1, 1998. RF tongue base reduction procedures are described in Powell et al., “Radiofrequency tongue base reduction in sleep-disordered breathing: A pilot study”, Otolaryngol. Head Neck Surg., Vol. 120, pp. 656-664. (1999) and Powell et al., “Radiofrequency Volumetric Reduction of the Tongue—A Porcine Pilot Study for the Treatment of Obstructive Sleep Apnea Syndrome”, Chest, Vol. 111, pp. 1348-1355 (1997).
  • [0008]
    A surgical hyoid expansion to treat OSA is disclosed in U.S. Pat. No. 6,161,541 to Woodson dated Dec. 19, 2000. Other tongue treatments for OSA include stimulation of the hypoglossal nerve. This procedure is described in Eisle et al., “Direct Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea”, Arch. Otolaryngol. Head Neck Surg., Vol. 123, pp. 57-61 (1997).
  • [0009]
    Commonly assigned U.S. patent applications Publication Nos. US 2005/0092332 A1 and US 2005/0092334 A1 (both published May 5, 2005) describe tongue-based treatments to treat obstructive sleep apnea. U.S. patent application Ser. Nos. 11/107,160 and 11/107,161 (both filed Apr. 15, 2005 and assigned to the assignee of the present invention) describe various implants for a tongue to treat obstructive sleep apnea.
  • [0010]
    European Patent EP 1,039,859 B1 granted Dec. 3, 2003 describes a brace placed in the tongue. German Patent No. 19 920 114 describes struts in pharyngeal wall. U.S. patent applications Publication Nos. US 2005/0126563 A1 published Jun. 16, 2005 and US 2005/0199248 A1 published Sep. 15, 2005 describe stents in an airway. U.S. patent applications Publication Nos. US 2004/0139975 published Jul. 22, 2004 and US 2004/0149290 published Aug. 5, 2005 (both assigned to Apneon Inc.) describe struts or magnets in the tongue.
  • II SUMMARY OF THE INVENTION
  • [0011]
    According to a preferred embodiment, obstructive sleep apnea of a patient is treated by identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient. The method includes identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue and stiffening a tissue of the tongue throughout the identified region.
  • III BRIEF DESCRIPTION OF THE DRAWINGS
  • [0012]
    FIG. 1 is a side sectional schematic view of an upper airway of a patient and illustrating various anatomical features;
  • [0013]
    FIG. 2 is the view of FIG. 1 showing an implant of the present invention placed within the tongue according to a treatment method of the present invention;
  • [0014]
    FIG. 3 is a side elevation view of the implant of FIG. 1;
  • [0015]
    FIG. 4 is a perspective view of the implant of FIG. 3;
  • [0016]
    FIG. 5 is the view of FIG. 1 showing an incision formation tool placed within the tongue;
  • [0017]
    FIG. 6 is the view of FIG. 5 with the incision formation tool actuated to an open position to form a pocket for receiving the implant of FIG. 3;
  • [0018]
    FIG. 6A is a view taken along line 6A-6A in FIG. 6;
  • [0019]
    FIG. 7 is the implant of FIG. 3 disposed on an implant insertion tool before final deployment;
  • [0020]
    FIG. 8 is a view taken along line 8-8 of FIG. 7;
  • [0021]
    FIG. 9 is the view of FIG. 7 with the implant insertion tool moved to an open position to fully place the implant within a pocket formed within the tongue;
  • [0022]
    FIG. 10 is the view taken alone line 10-10 of FIG. 9;
  • [0023]
    FIG. 11 is the top plan view of a tongue showing positioning of two implants within the tongue;
  • [0024]
    FIG. 12 is a view taken along line 12-12 of FIG. 11;
  • [0025]
    FIG. 13 is a top plan view of a tongue showing an entire target region being stiffened;
  • [0026]
    FIG. 14 is the view of FIG. 1 showing the entire target region of FIG. 13;
  • [0027]
    FIG. 15 is the view of FIG. 2 showing an alternative embodiment of an implant according to the present invention showing multiple implants in the tongue;
  • [0028]
    FIG. 16 is a perspective view of a tubular implant used in the embodiment of FIG. 15;
  • [0029]
    FIG. 16A is an end elevation view of the implant of FIG. 16;
  • [0030]
    FIG. 17 is a top plant view of a tongue with implants of FIG. 16 arranged extending along an anterior-posterior axis of the tongue; and
  • [0031]
    FIG. 18 is the view of FIG. 17 with the implants disposed in the target region of FIG. 13.
  • IV DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0032]
    With reference now to the various drawing figures in which identical elements are numbered identically throughout, a description of the preferred embodiment of the present invention will now be provided.
  • [0033]
    FIG. 1 is a schematic representation of an upper airway of a patient. FIG. 1 shows the tongue T with a tongue base TB opposing a pharyngeal wall PW. The hard palate HP and soft palate SP reside over the top of tongue T with the soft palate SP extending rearward to a trailing end TE between the tongue base TB and the pharyngeal wall PW.
  • [0034]
    A hyoid bone HB resides near the bottom of the tongue near an epiglottis E. A mandible or jaw bone JB is at the front of the tongue T. The geniohyoid muscle GH extends between the jaw bone JB and the hyoid bone HB at the bottom of the tongue T. The lines A of FIG. 1 illustrate the direction of muscle fibers in the geniohyoid muscle GH. The genioglossus muscle GG resides above the geniohyoid muscle GH. The genioglossus muscle GG has muscle fibers B which extend from the jaw bone JB and curve to radiate toward the surface of the tongue T.
  • [0035]
    When reclining during sleep, the tongue base TB may, in response to gravity or airflow, drop down in closer approximation to the pharyngeal wall PW. During sleep, the muscles of the tongue T (principally the genioglossus muscle GG) can stretch permitting the tongue T to fall back toward the pharyngeal wall PW.
  • [0036]
    The present invention is directed towards method and apparatus for stiffening the muscles of the tongue T in a manner to preclude the tongue T from falling toward the pharyngeal wall PW while avoiding interference with normal functions of the tongue T during speech and eating.
  • [0037]
    FIG. 2 illustrates the present invention as an implant 10 placed within the interior of the tongue T. The implant 10 has a proximal end 12 and a distal end 14. In a preferred embodiment, the implant 10 is a substantially planar sheet formed as a generally conical envelope best illustrated in FIG. 4. The distal end 14 is the base of a cone with opposing edges of the base being stitched or otherwise bonded together so that the interior of the implant 10 is accessible only through the proximal end 12. The implant 10 is a flat sheet with opposing surfaces of the cone compressed against one another.
  • [0038]
    The implant 10 is sized to be received within the tongue T with the proximal end 12 positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH. The height of the proximal end 12 (illustrated as HP in FIG. 3) is sized for the proximal end 12 to be received within the tongue T at the juncture of the jaw bone JB and the geniohyoid muscle GH. The implant 10 is further sized to have a length L for the distal end 14 to be positioned adjacent the tongue base TB in close proximity to the tongue base TB when the proximal end 12 is positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH. The height of the distal end 14 (illustrated as HD in FIG. 3) is sized for the distal end 14 to extend within the tongue base TB substantially covering a region of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the trailing end TE of the soft palate TB. By way of non-limiting example, representative dimensions for HP, HD and L are 1.0 centimeter, 2.5 centimeters and 4 centimeters, respectively. The fibrils of the material of implant 10 are about 20 microns to 100 microns in diameter. Depending on the braid or weave and the fibril diameter, the thickness of a sheet of the material may range from 50 to 500 microns. A double thickness TH (FIG. 12) (which is transverse to the anterior-posterior axis of the tongue T following implantation) would be about 100 to 1000 microns.
  • [0039]
    The material of the implant 10 is selected to produce a fibrotic response from the tissue of the tongue T following implantation of the implant 10 within the tongue T. The specific materials and construction may be varied to alter the degree of fibrotic response resulting from such implantation. By way of non-limiting example, the material of the implant 10 may be a knit or woven polyester or polypropylene material known to result in a fibrosis formation following implantation.
  • [0040]
    FIGS. 5-10 illustrate a technique and tools for placement of the implant 10 within the tongue. In FIG. 5, a tool 20 is shown for forming an incision in the tongue T sized to receive the implant 10. The tool 20 includes a curved handle 22 and a scissors end 24. The scissors end 24 is hinged to the handle at hinge point 26 and includes a pair of scissor blades 28, 30 (shown in FIG. 6). The tips 29, 31 of the blades 30, 28 are sharp to permit insertion of the tips 29, 31 through tissue into the tongue T. Further, the edges 27, 33 of the blades 28, 30 are sharp to permit slicing action of the scissor blades 28, 30 through tissue.
  • [0041]
    In use, the blades 28, 30 are collapsed so that they are in parallel alignment as shown in FIG. 5. The tips 31, 29 are passed through the patient's open mouth and are inserted into the tongue T at the front lower extremity of the tongue T just behind the jaw bone JB. Insertion is first made by urging the tips 29, 31 downwardly into the region of interface between the geniohyoid muscle GH and the jaw bone JB and then curving the direction of travel upwardly to urge the tips 29, 31 toward the tongue base TB.
  • [0042]
    When the tool 20 is in the position of FIG. 5, the scissor blades 28, 30 are opened as shown in FIG. 6 to cut a pocket for receiving an implant 10. The tool 20 is then removed. The arcuate nature of the handle 22 permits formation of an incision pocket extending from the geniohyoid muscle GH at the jaw JB toward the tongue base TB between the epiglottis E and the trailing end TE of the soft palate SP.
  • [0043]
    Following formation of the pocket, an insertion tool 40 is provided as illustrated in FIG. 7. Insertion tool 40 is similar in construction to the incision formation tool 20. It includes a curved handle 42 and scissor action blades 44, 46. Unlike blades 28, 30, the blades 44, 46 do not have knife edges in order to avoid damage to the implant 10.
  • [0044]
    With the blades 44, 46 in parallel alignment as shown in FIGS. 7 and 8, the tips of the blades 44, 46 are inserted into the interior of the implant 10 through the proximal end 12. The implant 10 can then be folded surrounding the blades 44, 46 into a compact configuration surrounding the blades 44, 46 as shown in FIGS. 7 and 8. The tool 40 carrying the implant 10 is placed into the incision pocket formed by tool 20. Such positioning is shown in FIG. 7. After such positioning, the blades 44, 46 are actuated to an open position shown in FIG. 9 urging the implant 10 to its expanded state. The blades 44, 46 can then be returned to their collapsed state and removed from the tongue T leaving the implant 10 in desired position within the tongue T.
  • [0045]
    As mentioned, it is desired that the proximal end 12 of the implant 10 be as positioned as close as possible to the jaw bone JB in the region of the geniohyoid muscle GH. If necessary, the surgeon can form additional incisions through the tongue T to pull the proximal end 12 into the geniohyoid muscle GH in close proximity to the jaw bone JB.
  • [0046]
    FIG. 11 shows two implants 10, 10′ positioned within the tongue T in the manner such as that previously described. Ideally, the implants 10, 10′ extend along the anterior posterior A-P axis. The proximal ends 12, 12′ are positioned in close approximation to the anterior-posterior axis A-P. Preferably, the implants 10, 10′ do not extend straight back. Instead, they are angled outwardly toward the sides of the tongue T. As a result, the distal ends 14, 14′ are spaced apart at opposite lateral extremities of the tongue base TB.
  • [0047]
    Following implantation, a fibrotic capsule FC forms around the material of the implant 10. The capsule FC is illustrated in FIG. 12. The fibrotic capsule FC adds stiffness to the tissue of the tongue T.
  • [0048]
    At the juncture of the geniohyoid muscle GH and the jaw bone JB (referred to herein as the “mandibular-geniohyoid interface”, muscle fibers of the tongue are tendon-like. By “tendon-like”, it is meant the muscle fibers are less susceptible to stretching than the remainder of the length of the fibers. Since the fibrotic capsule FC and the proximal end 12 of the implant 10 originate in this region, a substantially non-stretchable region is formed in the tongue T by reason of the fibrotic capsule FC and the implant 10.
  • [0049]
    In the absence of an implant 10, substantially the entire length of muscle fibers from the jaw bone JB to the tongue base TB can stretch during sleep resulting in the tongue base TB falling against the soft palate SP or pharyngeal wall PW during sleep. With the implant 10 extending from the jaw bone JB to the tongue base TB, the muscle fibers in contact with the implant 10 and resulting fibrotic capsule FC are much less susceptible to stretching.
  • [0050]
    Use of two implants 10, 10′ (FIG. 11) forms two such non-stretchable planes within the tongue T. The placement of FIG. 11 ties the tongue base TB to the jaw bone JB with the lateral extremities of the tongue based TB being treated to resist stretching. If desired, a third implant could be placed along the anterior-posterior axis A-P to further resist tongue stretching.
  • [0051]
    FIGS. 13 and 14 illustrate extreme treatments where the entire volume of the tongue from the mandibular-geniohyoid interface to the base of the tongue is stiffened. This volume V is illustrated in FIGS. 13 and 14 as a shaded area. The volume is defined as a generally conical volume having an apex at the mandibular-geniohyoid interface. The base of the conical volume is at the tongue base TB near the surface of the tongue and covering the portion of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the training end TE of the soft palate SP. The volume V extends between the lateral extremities of the tongue base TB.
  • [0052]
    Treatment of the entire volume can be accomplished by multiple implants 10 placed as described above. Alternatively, the volume V can be injected with any fibrosis-inducing agent (e.g., microbeads) throughout the volume V.
  • [0053]
    Ideally, the implant 10 will contract and expand with the muscle as it heals. Otherwise, a capsule surrounding the implant 10 will form as muscle slides over the implant 10. This property is enabled by a combination of factors: the restoring force of the implant 10, the friction against the tissue and attachments if any at either end. The mesh material of the implant 10 aids in achieving these objectives. The goal is to have an appropriate amount of spring tension/expansion and wall friction/in-growth such that the implant 10 contracts and expands with tissue. It is desirable to avoid an implant so stiff as to overly contract the muscle. This may cause the distal end of the implant to slide more proximal. As the scar forms and contracts, the implant contracts more permanently with the scar. This suggests the restoring force decreases over time. Biodegradable fibers suitable for this purpose or biodegradable coatings on the fibers themselves (which adhere the fibers together) may be used. The elastic properties of the implant should are approximately between 5 kPa to 50 kPa. The frictional force should be approximately 2N to 4 N. The patient's physiology and the size of the implant affect the range for these values.
  • [0054]
    FIGS. 15-18 illustrate an alternative embodiment in which the target area or volume of the tongue is stiffened by placement of a plurality of tubular implants 10″. One such implant 10″ is separately shown in FIGS. 16 and 16A. In a representative embodiment, the implant 10″ is tube of polyester or other material selected to induce fibrosis following implantation in the tongue T. The implant 10″ has a length L′ of 3-5 centimeters, an outside diameter DO of about 1 mm to 3 mm and an inside diameter DI resulting from a wall thickness of about 50 to 500 microns. Implants 10″ for a single patient need not all be the same length L′. More interior implanted tubes 10″ may be shorter so that proximal ends 12″ do not impinge upon one another when multiple implants 10″ are used (as will be described).
  • [0055]
    The implant 10″ may be placed with a proximal end 12″ at the mandibular-geniohyoid interface and with a distal end 14″ at the tongue base TB. FIG. 15 shows three such implants 10″ disposed in a vertical planar array 16″ substantially filling the plane of implant 10 of FIG. 2. A single such array 16″ may be positioned in line with the anterior posterior axis A-P (as shown in FIG. 17) or multiple such arrays 16″ may be positioned similar to the positioning of implants 10 in FIG. 11 (as illustrated in FIG. 18). Use of tubular implant 10″ permits a more uniform distribution of implants in the target volume V and creation of a filled target volume of more conical shape.
  • [0056]
    The insertion tool for the tube shaped implants 10″ may be much like the insertion tool described in U.S. patent application Publication No. 2005/0154412 A1 (incorporated herein by reference) which describes a tool for placing a solid braided implant such as that marketed by assignee of the present application (Restore Medical Inc., St. Paul, Minn., USA) under the trademark “Pillar”. The tool may be modified to replace the needle of the tool with a rod received within the implant 10″ through the proximal end 12″. The rod may extend to the distal tip 14″ of the implant 10″. Retracting the rod leaves the implant 10″ in desired position in the tongue T.
  • [0057]
    In the foregoing example, no stiffening treatment is made in the tongue T in the upper region of the tongue T. Generally defined herein as the region of the tongue T above and forward of a line from the jaw bone JD to the trailing end of the hard palate HP, this region of the tongue T is active in speech and swallowing. Since no treatment is made in this region, these functions are not impaired.
  • [0058]
    It has been shown how the present invention has been obtained in a preferred embodiment. Modifications and equivalents of the disclosed concepts are intended to be included within the scope of the claims which are appended hereto.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4193137 *May 6, 1977Mar 18, 1980Meadox Medicals, Inc.Warp-knitted double-velour prosthesis
US4347847 *Jun 6, 1980Sep 7, 1982Usher Francis CMethod of hernia repair
US4655771 *Apr 11, 1983Apr 7, 1987Shepherd Patents S.A.Prosthesis comprising an expansible or contractile tubular body
US4672673 *Apr 22, 1985Jun 9, 1987Thomas Jefferson UniversityArtificial larynx
US5258000 *Nov 25, 1991Nov 2, 1993Cook IncorporatedTissue aperture repair device
US5522896 *Apr 1, 1994Jun 4, 1996Xomed, Inc.Biocompatible composite material
US5578086 *Apr 10, 1995Nov 26, 1996Xomed, Inc.Prosthesis using biocompatible composite material
US5843021 *Aug 5, 1997Dec 1, 1998Somnus Medical Technologies, Inc.Cell necrosis apparatus
US5988171 *Jun 26, 1997Nov 23, 1999Influence Medical Technologies, Ltd.Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US6161541 *Jun 9, 1999Dec 19, 2000Influent Ltd.Hyoid expansion and suspension procedure
US6250307 *Sep 17, 1999Jun 26, 2001Pi Medical, Inc.Snoring treatment
US6413254 *Jan 19, 2000Jul 2, 2002Medtronic Xomed, Inc.Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6431174 *Aug 10, 2000Aug 13, 2002Pi Medical, Inc.Method and apparatus to treat conditions of the naso-pharyngeal area
US6513530 *Mar 21, 2001Feb 4, 2003Pi Medical, Inc.Braided palatal implant for snoring treatment
US6523541 *Mar 21, 2001Feb 25, 2003Pi Medical, Inc.Delivery system for snoring treatment implant and method
US6523542 *Mar 21, 2001Feb 25, 2003Pi Medical, Inc.Snoring treatment implant and method
US6601584 *Mar 21, 2001Aug 5, 2003Pi Medical, Inc.Contracting snoring treatment implant
US6736823 *May 10, 2002May 18, 2004C.R. Bard, Inc.Prosthetic repair fabric
US6918396 *Dec 1, 1999Jul 19, 2005Purdue Research FoundationMethod for vocal cord reconstruction
US6955172 *Sep 6, 2002Oct 18, 2005Apneon, Inc.Systems and methods for moving and/or restraining the tongue in the oral cavity
US6997956 *Mar 19, 2003Feb 14, 2006Anulex Technologies, Inc.Spinal disc annulus reconstruction method and spinal disc annulus stent
US7048753 *Mar 1, 2002May 23, 2006Poly-Med, Inc.Coated, slow-absorbing textile constructs for sutures and tissue engineering
US7073505 *Sep 6, 2002Jul 11, 2006Apneon, Inc.Systems and methods for moving and/or restraining tissue in the oral cavity
US7078378 *Jun 18, 1999Jul 18, 2006Avastra Ltd.Method of tissue repair II
US7081086 *Feb 27, 2004Jul 25, 2006Paracor Medical, Inc.Expandable cardiac harness for treating congestive heart failure
US20020083820 *Oct 10, 2001Jul 4, 2002Greenhalgh E. SkottStiffened fabric
US20040020492 *Apr 25, 2003Feb 5, 2004Dubrul William R.Upper airway device and method
US20040028676 *Aug 6, 2002Feb 12, 2004Klein Dean A.Swallowing system tissue modifier
US20040045556 *Sep 6, 2002Mar 11, 2004Swan MedicalSystems and methods for moving and/or restraining tissue in the upper respiratory system
US20040134491 *Jul 22, 2003Jul 15, 2004Quiescence MedicalApparatus and methods for treating sleep apnea
US20040139975 *Sep 6, 2003Jul 22, 2004Apneon, Inc.Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
US20040149290 *Nov 20, 2003Aug 5, 2004Apneon, Inc.Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US20050004417 *Mar 22, 2004Jan 6, 2005Apneon, Inc.Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US20050092332 *Oct 31, 2003May 5, 2005Restore Medical, Inc.Airway implant
US20050092334 *Jun 24, 2004May 5, 2005Restore Medical, Inc.Airway implant
US20050126563 *Dec 15, 2003Jun 16, 2005Van Der Burg Erik J.System and method for hyoidplasty
US20050142163 *Dec 1, 2004Jun 30, 2005Angiotech International AgMedical implants and fibrosis-inducing agents
US20050154412 *Feb 25, 2005Jul 14, 2005Restore Medical, Inc.Airway implant and delivery tool
US20050199248 *May 10, 2005Sep 15, 2005Quiescence Medical, Inc.Apparatus and methods for treating sleep apnea
US20050267321 *Jun 1, 2005Dec 1, 2005Shadduck John HElastomeric magnetic nanocomposite biomedical devices
US20050281883 *Apr 28, 2005Dec 22, 2005Daniloff George YCompositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US20060029591 *Jul 28, 2005Feb 9, 2006Stryker CorporationRepair of larynx, trachea, and other fibrocartilaginous tissues
US20060070626 *Oct 4, 2004Apr 6, 2006Andrew FrazierSystem and method for airway manipulation
US20060153816 *Dec 22, 2005Jul 13, 2006Laura BrownSoft tissue repair and regeneration using postpartum-derived cells and cell products
US20060157055 *Dec 30, 2003Jul 20, 2006Pflueger D RApparatus and methods for treating sleep apnea
US20060235264 *Apr 15, 2005Oct 19, 2006Restore Medical, Inc.Implant for tongue
US20060235380 *Apr 15, 2005Oct 19, 2006Restore Medical, Inc.Tissue incision tool
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8167787Jan 3, 2008May 1, 2012Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US8307831Mar 16, 2009Nov 13, 2012Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US8327854Oct 7, 2011Dec 11, 2012Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US8413661Aug 14, 2008Apr 9, 2013Ethicon, Inc.Methods and devices for treatment of obstructive sleep apnea
US8523760Apr 10, 2012Sep 3, 2013Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US8556797Jul 31, 2008Oct 15, 2013Ethicon, Inc.Magnetic implants for treating obstructive sleep apnea and methods therefor
US8561616Oct 24, 2008Oct 22, 2013Ethicon, Inc.Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US8561617Oct 30, 2008Oct 22, 2013Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US8632488Dec 15, 2009Jan 21, 2014Ethicon, Inc.Fluid filled implants for treating medical conditions
US8678008Jul 30, 2008Mar 25, 2014Ethicon, IncMethods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8695607Dec 7, 2009Apr 15, 2014Sileomed, Inc.Apparatus, systems, and methods for constraining and/or supporting tissue structures along an airway
US8707960May 11, 2009Apr 29, 2014Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US8733363Mar 21, 2011May 27, 2014Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US8747296Jul 30, 2013Jun 10, 2014Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US8776799Mar 21, 2011Jul 15, 2014Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US8783258Dec 1, 2008Jul 22, 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US8800567Oct 13, 2009Aug 12, 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US8813754Jan 7, 2013Aug 26, 2014Ethicon, Inc.Magnetic implants and methods for treating an oropharyngeal condition
US8905033Sep 28, 2011Dec 9, 2014Ethicon, Inc.Modular tissue securement systems
US8915252Mar 8, 2013Dec 23, 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US8973582Nov 30, 2011Mar 10, 2015Ethicon, Inc.Tongue suspension device and method
US8991398Dec 11, 2012Mar 31, 2015Revent Medical, Inc.Partially erodable systems for treatment of obstructive sleep apnea
US9144511Mar 4, 2013Sep 29, 2015Ethicon, Inc.Methods and devices for treatment of obstructive sleep apnea
US9161855Oct 24, 2011Oct 20, 2015Ethicon, Inc.Tissue supporting device and method
US9173766Jun 1, 2012Nov 3, 2015Ethicon, Inc.Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
US9326886Oct 29, 2009May 3, 2016Ethicon, Inc.Fluid filled implants for treating obstructive sleep apnea
US9381109 *May 28, 2014Jul 5, 2016Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US9439801Jun 29, 2012Sep 13, 2016Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US9510922May 23, 2011Dec 6, 2016Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US9592046May 30, 2014Mar 14, 2017Ethicon, Inc.Modular tissue securement systems
US9643022Jun 17, 2014May 9, 2017Nyxoah SAFlexible control housing for disposable patch
US9707122Jul 21, 2011Jul 18, 2017Revent Medical, Inc.Systems and methods for treatment of sleep apnea
US9849289Jun 17, 2014Dec 26, 2017Nyxoah SADevice and method for snoring detection and control
US20080261886 *May 28, 2008Oct 23, 2008Novo Nordisk Healthcare A/GSingle-Dose Administration of Factor VIIa
US20090177027 *Jan 3, 2008Jul 9, 2009Gillis Edward MPartially erodable systems for treatment of obstructive sleep apnea
US20100024830 *Jul 30, 2008Feb 4, 2010Ethicon, Inc.Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US20100030011 *Jul 31, 2008Feb 4, 2010Ethicon, Inc.Magnetic implants for treating obstructive sleep apnea and methods therefor
US20100037901 *Aug 14, 2008Feb 18, 2010Rousseau Robert AMethods and devices for treatment of obstructive sleep apnea
US20100108077 *Oct 30, 2008May 6, 2010Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US20100132719 *Dec 1, 2008Jun 3, 2010Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US20100163056 *Dec 7, 2009Jul 1, 2010Medartis AgImplant
US20100294284 *Dec 7, 2009Nov 25, 2010H-MedicalApparatus, systems, and methods for constraining and/or supporting tissue structures along an airway
US20110100378 *Oct 30, 2009May 5, 2011Ethicon, Inc.Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US20110226262 *Mar 21, 2011Sep 22, 2011Gillis Edward MSystems and methods for treatment of sleep apnea
US20110226263 *Mar 21, 2011Sep 22, 2011Gillis Edward MSystems and methods for treatment of sleep apnea
US20140007885 *Jul 3, 2013Jan 9, 2014Edward M. GillisSystems and methods for treatment of sleep apnea
US20140261451 *May 28, 2014Sep 18, 2014Edward M. GillisSystems and methods for treatment of sleep apnea
WO2011059629A1 *Oct 14, 2010May 19, 2011Ethicon, Inc.Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
Classifications
U.S. Classification128/848
International ClassificationA61F5/56
Cooperative ClassificationA61F5/566
European ClassificationA61F5/56B
Legal Events
DateCodeEventDescription
Jul 11, 2006ASAssignment
Owner name: IBIDL GMBH, GERMANY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAHL, JOHAN-VALENTIN;ZANTI, ROMAN;REEL/FRAME:017924/0935
Effective date: 20060602
Oct 3, 2006ASAssignment
Owner name: RESTORE MEDICAL, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BUSCEMI, PAUL J.;KRUEGER, KURT D.;REEL/FRAME:018381/0745
Effective date: 20061002